Home4XC1 • FRA
add
Kalvista Pharmaceuticals Inc
Previous close
€11.50
Day range
€12.40 - €12.40
Year range
€6.95 - €14.00
Market cap
721.30M USD
Avg Volume
93.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Revenue | 1.43M | — |
Operating expense | 44.68M | 153.87% |
Net income | -60.10M | -48.59% |
Net profit margin | -4.21K | — |
Earnings per share | -1.12 | -28.74% |
EBITDA | -58.76M | -33.57% |
Effective tax rate | -3.72% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 191.46M | 9.87% |
Total assets | 215.50M | 7.65% |
Total liabilities | 174.72M | 537.67% |
Total equity | 40.79M | — |
Shares outstanding | 50.52M | — |
Price to book | 14.20 | — |
Return on assets | -63.28% | — |
Return on capital | -76.27% | — |
Cash Flow
Net change in cash
| (USD) | Jul 2025info | Y/Y change |
|---|---|---|
Net income | -60.10M | -48.59% |
Cash from operations | -54.50M | -35.51% |
Cash from investing | 21.26M | -42.79% |
Cash from financing | 23.21M | 673.67% |
Net change in cash | -7.31M | -12,486.44% |
Free cash flow | -34.18M | -27.14% |
About
Founded
2004
Headquarters
Website
Employees
270
